DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Butaxamine
Butaxamine
(12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al
Autonomic Nervous System Final.Pdf
General Prescription
Drug-Facilitated Sexual Assault Panel, Blood
Use of Non-Selective Β-Blockers Is Associated with Decreased Tumor Proliferative Indices in Early Stage Breast Cancer
Influence of Obesity and Exercise
Developing Novel Therapeutic Agents for Acanthamoeba Infection and Investigating the Process of Encystment
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Olodaterol Exerts Anti-Inflammatory Effects on COPD Airway Epithelial Cells
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Principal Component Analysis of HPLC Retention Data and Molecular Modeling Structural Parameters of Cardiovascular System Drugs
Repurposing Drugs in Oncology (Redo) —Propranolol As an Anti-Cancer Agent
A Study on Beta Blockers - a Brief Review Tv
Pharmaceuticals Appendix
(12) United States Patent (10) Patent No.: US 8,759,364 B2 Karsenty Et Al
Marrakesh Agreement Establishing the World Trade Organization
Drugs 2010; 70 (1): 41-56 REVIEW ARTICLE 0012-6667/10/0001-0041/$55.55/0 ª 2010 Adis Data Information BV
Top View
Sgc Stimulators Sgc-Stimulatoren Stimulateurs De Sgc
Comprehensive Panel, Blood
(12) United States Patent (10) Patent No.: US 9.248,185 B2 Rubin Et Al
The Role of Dental Metal Allergy in Oral Lichen Planus
Non-Target Screening ‒ a Powerful Tool for Selecting Environmental Pollutants
)&F1y3x PHARMACEUTICAL APPENDIX to the HARMONIZED
Wo 2009/080693 A2
Pharmaceutical Appendix to the Tariff Schedule 2
Study Protocol on Clinicaltrials.Gov
Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
Β-Blockers: a Systematic Review
This Thesis Has Been Submitted in Fulfilment of the Requirements for a Postgraduate Degree (E.G
WO 2009/134336 Al
(51) International Patent Classification: A61K 31/506 (2006.01) C07F 9/09 (2006.01) C07D 487/04 (2006.01) AO, AT, AU, AZ, BA, BB
Pharmaceutical Appendix to the Harmonized Tariff Schedule
HIF-1Α Links Β-Adrenoceptor Agonists and Pancreatic Cancer Cells Under Normoxic Condition
Pharmaceutical Appendix to the Tariff Schedule 2
And Β3-Adrenoceptor Agonists on Contractile Activity of the Porcine Myometrium in the Luteal Phase and the First Days of Pregnancy
WO 2017/106175 A2 22 June 2017 (22.06.2017) W P O P C T
Propranolol As an Anti-Cancer Agent
Naming of Drugs
Identification and Characterization of Antidiabetic And
Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement
Propranolol As an Anti-Cancer Agent
WO 2016/109501 Al 7 July 2016 (07.07.2016) W P O P C T